Real-time enrollment status for this metastatic melanoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT07504796 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | August 24, 2026 (Aug 24, 2026) |
As of October 15, 2026: Clinical trial NCT07504796 is currently recruiting participants. This phase2 study for metastatic melanoma is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07504796 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07504796 was last updated Aug 24, 2026 (August 24, 2026). HelloStudys verifies this status automatically.